Found 127 matching trials
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
PHASE2This phase II trial tests how well giving dasatinib and quercetin with cycl...
Location
Mayo Clinic in Rochester
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
PHASE1This study is a single-center, open Phase I study, to observe the effective...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
PHASE1CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Location
Children's Hospital, Zhejiang University School of Medicine
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma
PHASE1This phase I trial studies the side effects and best dose of BCMA CART cell...
Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT
PHASE2This is a prospective study comparing autologous hematopoietic stem cell tr...
Location
The Affiliated Hospital oh Xuzhou Medical University
BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma
PHASE1This was a first-in-human study to evaluate the feasibility, safety and pre...
Location
Uni of Chi Medi Ctr Hema and Onco
Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS
PHASE1This is an investigator-initiated trial aimed at assessing the safety and e...
Location
Children's Hospital, Zhejiang University School of Medicine
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
PHASE2The goal of this clinical trial is to test the safety and potential benefit...
Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
PHASE1This is a single-center, non-randomized study to evaluate the safety and ef...
Location
Peking Union Medical College Hospital
Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
PHASE1This study is a single-armed, open-label, multicenter Phase 1/2 study to ev...
Location
Institute of Science Tokyo Hospital